Search results for " china" in Articles / App Notes

Article Healthcare Reform in China
These initiatives include expansion of public healthcare services, lifting the restrictions of foreign investments in mainland China, and extending healthcare to rural areas. This move is in line with…

Article USP Stresses Pharmacopeial Standards at CPhI China
Jun 29, 2015 By BioPharm International Editors The United States Pharmacopeial Convention (USP) hosted a pharmacopeial and regulatory compliance seminar at the 2015 CPhI China conference, he…

Article KUBio modular biopharm facility built in Germany, assembled in China
The sixty-two completed modules that make up the factory have completed the journey from Germany to China are now assembled at the facility at the Biolake Science Park. Watch the video.

Article These 17,000 Meters of Land in China will House Advanced Labs and Manufacturing for Future Therapeutics
Leading supplier to the biopharma industry will open a manufacturing facility in Guangzhou using KUBio, the “factory-in-a-box”, to more efficiently deliver targeted treatments. Read the article h…

Article Biomanufacturing Outsourcing Globalization Continues
Top outsourcing destinations Offshoring for biologics has been generally equated with emerging hubs in Asia, especially Singapore, China, India, or Korea. This trend is changing, as domestic CMOs …

Article Global Expansion Shapes Drug Oversight
Challenges in India and China At the MHRA meeting, Hamburg commented on her visit to India in February and FDA efforts to expand inspections and develop stronger ties with local regulatory autho…

Article The Outlook for CMO Outsourcing in 2019
Among US respondents, China was the top destination, cited by more than 50%. Figure 2: Country selections as destination for international outsourcing of biomanufacturing. (Figure courtesy of t…

Article Pharma Investments Reflect Key Industry Trends
Bayer Healthcare is also investing $138 million to expand its packaging, logistics, and analytical capabilities at its facility in Beijing, China. Boehringer Ingelheim: After investing more than $…

Article A Bright Future for the Plasma Fractionation Industry
Global aspects on the manufacturing, supply, and hemophilia care in the rapidly growing markets of Asia, such as China and India, were presented by Ranjeet Ajmani from PlasmaGen and Jeff Davies from C…

Article Supply Chain Challenges for Single-Use Systems
In September 2018, MilliporeSigma announced its first Mobius single-use manufacturing facility in Wuxi, China would begin production in 2019 (2), and in November 2018, GE Healthcare announced a collab…

Show All Results

Next Page